Showing 1 - 10 of 353
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical stage targeting 11 emerging infectious diseases. We calibrate the simulation parameters with input from domain experts in mRNA technology and an extensive literature review. We find...
Persistent link: https://www.econbiz.de/10013334345
In a life-cycle model, a retiree faces stochastic health depreciation and chooses consumption, health expenditure, and the allocation of wealth between bonds, stocks, and housing. The model explains key facts about asset allocation and health expenditure across health status and age. The...
Persistent link: https://www.econbiz.de/10012463342
We discuss recent cases of Chinese buyout activity in the OECD (especially in the US and the EU) in resource and manufacturing sectors. While most of the buyout attempts have been unsuccessful, they can serve as a catalyst for a wider discussion on the implications for global arrangements over...
Persistent link: https://www.econbiz.de/10012466597
Persistent link: https://www.econbiz.de/10003757092
Persistent link: https://www.econbiz.de/10003757106
Persistent link: https://www.econbiz.de/10003740745
Persistent link: https://www.econbiz.de/10003777816
Persistent link: https://www.econbiz.de/10003777836
Persistent link: https://www.econbiz.de/10001047828
Persistent link: https://www.econbiz.de/10003353930